Skip to content

Opko Health OPK Deferred Taxes

Deferred Taxes at other companies

Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
$30M-0.2%
Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND
$22.61M-23.0%
Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$211M-23.6%
QuidelOrtho Corporation logo
QuidelOrtho CorporationQDEL
$87.3M+11.6%
Merck & Co. logo
Merck & Co.MRK
Amgen logo
AmgenAMGN

Other financials

Income statement

See full
Revenue$124.2M-17.2%
Gross profit$45.8M+7.4%
Operating income-$51.0M+24.0%
Net income-$54.8M+18.9%
EPS (diluted)-$0.07+30.0%

Balance sheet

See full
Cash & equivalents$40.6M-62.5%
Total debt$52.8M-4.2%
Total equity$1.2B-8.2%
Total assets$1.9B-12.8%

Cash flow

See full
Operating cash flow-$19.3M+44.1%
CapEx$1.8M-42.6%
Free cash flow-$21.1M+44.0%

Valuation

See full
Market cap$1.13B+10.0%
P/S1.9×+0.5×

Profitability

See full
Gross margin36%+4.2pp
Operating margin-17.4%-5.6pp
Net margin-36.6%-44.8pp
FCF margin-30%+0.1pp

Returns & leverage

See full
Return on equity-16.9%-21.7pp
Debt / equity0.0×
Current ratio3.6×+1.1×

Where this comes from

Reported directly by Opko Health in its filing.

Tagged under the XBRL concept us-gaap:DeferredIncomeTaxLiabilitiesNet.

The official record: Opko Health’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Opko Health's deferred taxes.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Opko Health's deferred taxes?
Opko Health (OPK) reported deferred taxes of $114.56M in Q1 2026.
How has Opko Health's deferred taxes changed year-over-year?
Opko Health's deferred taxes decreased by 11.5% year-over-year, from $129.44M to $114.56M.
What is the long-term trend for Opko Health's deferred taxes?
Over 5 years (2020 to 2025), Opko Health's deferred taxes has grown at a -1.7% compound annual growth rate (CAGR), from $137.21M to $126.24M.
What does deferred taxes mean?
This represents the net amount of income taxes that will be payable in future periods due to temporary differences between the carrying amount of assets and liabilities for financial reporting and their tax bases. It reflects the long-term tax impact of accounting choices and depreciation schedules. Investors use this to understand future tax obligations and the impact of tax timing on cash flow.